[{"NetIncomeLoss_1_Q1_USD":15662000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":8570000.0,"Liabilities_0_Q1_USD":476030000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":139286000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":7324000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":67181000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":16894000.0,"InterestPaidNet_1_Q1_USD":5746000.0,"InventoryFinishedGoods_0_Q1_USD":9685000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":2547000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-428000.0,"Depreciation_1_Q1_USD":439000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q1_USD":16795000.0,"CurrentFederalTaxExpenseBenefit_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":296311000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":31476000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":32123000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":4102000.0,"IncomeTaxesPaidNet_1_Q1_USD":418000.0,"CommonStockSharesIssued_0_Q1_shares":35203824.0,"Assets_0_Q1_USD":646065000.0,"ShareBasedCompensation_1_Q1_USD":6879000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":182790000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":8209000.0,"OtherAssetsNoncurrent_0_Q1_USD":129000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":16795000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q1_USD":15328000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2930000.0,"InventoryRawMaterials_0_Q1_USD":5011000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":202061000.0,"EarningsPerShareBasic_1_Q1_USD":0.45,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":67181000.0,"AccruedBonusesCurrent_0_Q1_USD":1011000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":41160092.0,"LoansPayableCurrent_0_Q1_USD":47705000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-8029000.0,"AccountsReceivableNetCurrent_0_Q1_USD":93156000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.683,"IncomeTaxExpenseBenefit_1_Q1_USD":-188000.0,"CommonStockValue_0_Q1_USD":35000.0,"NetIncomeLossAttributableToParentDiluted_1_Q1_USD":16827000.0,"InvestmentIncomeNet_1_Q1_USD":3000.0,"InterestPayableCurrent_0_Q1_USD":472000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-0.012,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-11468000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"WarrantsNotSettleableInCashFairValueDisclosure_0_Q1_USD":8043000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"IncreaseDecreaseInInventories_1_Q1_USD":400000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1350000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.005,"LongTermLoansPayable_0_Q1_USD":98006000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":67180000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":67181000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":15474000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":3508000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":6879000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":20570000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":34951740.0,"InventoryWorkInProcess_0_Q1_USD":802000.0,"LiabilitiesCurrent_0_Q1_USD":230168000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":8674000.0,"AccountsPayableCurrent_0_Q1_USD":8666000.0,"InterestExpense_1_Q1_USD":5721000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":185337000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":358000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4867000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":4182000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":578000.0,"InterestExpenseDebt_1_Q1_USD":1165000.0,"GrossProfit_1_Q1_USD":55598000.0,"AdditionalPaidInCapital_0_Q1_USD":482197000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":358000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":319109000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":19760000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"RepaymentsOfNotesPayable_1_Q1_USD":12500000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":560000.0,"CommonStockSharesOutstanding_0_Q1_shares":35203824.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":158234000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":115000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":87721000.0,"OperatingIncomeLoss_1_Q1_USD":21192000.0,"InventoryNet_0_Q1_USD":15498000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":521170000.0,"PreferredStockValue_0_Q1_USD":null,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":646065000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1931000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6879000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":63922000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":750000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":50386000.0,"OperatingExpenses_1_Q1_USD":34406000.0,"StockholdersEquity_0_Q1_USD":170035000.0,"AccruedMarketingCostsCurrent_0_Q1_USD":1378000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":428000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":319109000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":919000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-312197000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":9836000.0,"EarningsPerShareDiluted_1_Q1_USD":0.41,"AccruedProfessionalFeesCurrent_0_Q1_USD":599000.0,"Ticker":"COLL","CIK":"1267565","name":"COLLEGIUM PHARMACEUTICAL, INC","OfficialName":"Collegium Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"619097451.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]